Michael J Keiser

Michael J Keiser, Ph.D.

  • Position:
    President & COO

    SeaChange Pharmaceuticals, Inc

  •  
  • Advisor:

    Brian K Shoichet

  •  
  • Degrees:
     
    Ph.D., Bioinformatics, University of California, San Francisco (San Francisco, CA)
     
    B.Sc., Computer Science, Stanford University (Stanford, CA)
     
    B.A., Slavic Language and Literature, Stanford University (Stanford, CA)
     
    M.A., Russian, Eastern European & Eurasian Studies, Stanford University (Stanford, CA)
  •  
  • Past Advisors:
  •  
  • Research:
    Relating protein pharmacology by ligand chemistry
  •  
  • Other Experience:

    2009-2010 Postdoctoral Scholar, University of California, San Francisco

    2003-2004 Instructor, CS196, Stanford University

    2003-2004 Research assistant, Anesthesia & Pain Management, Stanford University (Mackey lab)

    2002 Research assistant, UC Santa Cruz Center for Biomolecular Science & Engineering (Haussler lab)

  •  
  • Honors:

    2010 Frank M Goyan Award [for excellence in physical chemistry]

    2009-2011 Rogers Bridging the Gap Award 2009 & 2010

    2009 Wired top 10 scientific breakthroughs of 2009 (No. 7)

    2006-2009 NSF Graduate Research Fellowship

    2006 UC BREP GREAT Grant (declined)

    2003-2004 US Dept. Education Foreign Languages and Area Studies Fellow

Life Sciences
Communities:

Michael Keiser's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.


Michael Keiser's Publications (12)



Michael Keiser's Posters and Presentations (7)

  • Predicting drug off-targets using ligand ensembles (presentation)

    Michael J Keiser, Shoichet BK

    EMBL‐EBI Industry Programme Workshop on Computational Drug Repositioning, Hinxton, UK; 06/2010
  • Predicting drug off-targets (presentation)

    Michael J Keiser, Shoichet BK

    Cambridge Healthtech Institute 9th Annual Bio-IT World Conference & Expo, Boston, MA; 04/2010
  • Predicting drug off-targets (presentation)

    Michael J Keiser, Shoichet BK

    Croucher ASI, Chinese University of Hong Kong; 12/2009
  • Drug repurposing & side-effect elucidation by statistical chemical similarity (presentation)

    Michael J Keiser, Shoichet BK

    eCheminfo Drug Discovery & Development, Bryn Mawr; 10/2008
  • Finding new uses for old targets: ligand chemistry relates protein pharmacology (presentation)

    Michael J Keiser, Shoichet BK

    6th Annual G-Protein Coupled Receptors Conference, Assays & Cellular Targets 2007, San Diego; 10/2007
  • Relating proteins by ligand chemistry (presentation)

    Michael J Keiser, Shoichet BK

    CHI Second Annual Drug Repositioning Summit, Philadelphia; 10/2007
  • Relating proteins by ligand similarity (presentation)

    Michael J Keiser, Shoichet BK

    Sixth European Workshop in Drug Design, Certosa di Pontignano, Italy; 06/2007

One Figure

One Figure for Michael J Keiser

Drug-target network. Each drug (gold) is linked to its known protein targets (cyan) by a gray edge. Red edges link drugs to newly predicted targets (Nature, Nov 2009).


Websites


Join Epernicus (membership is free)
Epernicus is open to current and former research scientists.
First name:
Last name:
Email:

(we don't share your email)

Already a member?
Sign in to view Michael's full profile.